An overview and a roadmap for artificial intelligence in hematology and oncology.

Journal: Journal of cancer research and clinical oncology
Published Date:

Abstract

BACKGROUND: Artificial intelligence (AI) is influencing our society on many levels and has broad implications for the future practice of hematology and oncology. However, for many medical professionals and researchers, it often remains unclear what AI can and cannot do, and what are promising areas for a sensible application of AI in hematology and oncology. Finally, the limits and perils of using AI in oncology are not obvious to many healthcare professionals.

Authors

  • Wiebke Rösler
    Department for Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.
  • Michael Altenbuchinger
    Department of Medical Bioinformatics, University Medical Center Göttingen, Göttingen, Germany.
  • Bettina Baeßler
    Department of Radiology, University Hospital of Cologne, Cologne, Germany.
  • Tim Beissbarth
    3 Department of Medical Statistics, University Medical Center Goettingen, Goettingen, Germany.
  • Gernot Beutel
    Department for Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Robert Bock
    IMMS Institute for Microelectronics and Mechatronics Systems GmbH (NPO), Ilmenau, Germany.
  • Nikolas von Bubnoff
    Department of Hematology and Oncology, Medical Center, University of Schleswig Holstein, Campus Lübeck, Lübeck, Germany.
  • Jan-Niklas Eckardt
    Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany. jan-niklas.eckardt@uniklinikum-dresden.de.
  • Sebastian Foersch
    Institute of Pathology, University Medical Center Mainz, Mainz, Germany. Electronic address: sebastian.foersch@unimedizin-mainz.de.
  • Chiara M L Loeffler
    Department of Medicine 1, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Jan Moritz Middeke
    Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Martha-Lena Mueller
    MLL Munich Leukemia Laboratory, Munich, Germany.
  • Thomas Oellerich
    Medizinische Klinik 2-Haematology/Oncology, University Hospital, Frankfurt am Main, Germany.
  • Benjamin Risse
    Faculty of Mathematics and Computer Science, University of Münster, Münster, Germany.
  • André Scherag
    Institute of Medical Statistics, Computer and Data Sciences, Jena University Hospital - Friedrich Schiller University, Jena, Germany.
  • Christoph Schliemann
    Department of Medicine A, University Hospital Münster, Münster, Germany.
  • Markus Scholz
    Institute for Medical Informatics, Statistics and Epidemiology, Medical Faculty, University of Leipzig, Leipzig, Germany; LIFE Research Center of Civilization Diseases, Leipzig, Germany.
  • Rainer Spang
    Department of Statistical Bioinformatics, University of Regensburg, Regensburg, Germany.
  • Christian Thielscher
    Competence Center for Medical Economics, FOM University, Essen, Germany.
  • Ioannis Tsoukakis
    Department of Hematology and Oncology, Sana Klinikum Offenbach, Offenbach, Germany.
  • Jakob Nikolas Kather
    Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.